Hearing Innovation Fund

Hearing Innovation Fund is a Chicago-based specialized angel and seed fund backing early-stage prototypes and therapeutics targeting hearing loss and audiology. Among the earliest-stage and smallest-check hearing-focused investors in this batch, the fund operates in a category that combines an aging-population tailwind with a recent regulatory shift in the United States to allow over-the-counter hearing aids. Founders building hearing aid hardware, audiology workflow software, hearing screening and tele-audiology platforms, regenerative therapeutics for sensorineural hearing loss, tinnitus treatments, and accessibility audio products fit the thesis.

The fund invests at Pre-Seed and Seed with check sizes under $250k. It is based in the United States and concentrates on medical devices and MedTech. There is no stated AI focus.

Founders should approach as they would an angel network, with a tight pitch, a working prototype or strong preclinical signal, and clarity on the next milestone the small check enables. The fund’s narrow vertical means founders can expect domain-relevant diligence rather than generalist evaluation. Limited public information is available about specific partners and complete portfolio. Outreach via the firm’s website, audiology industry events, and referrals through hearing industry operators or academic audiology departments are typical entry paths.